)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Aktis Oncology
Aktis Oncology (AKTS) investor relations material
Aktis Oncology Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary18 Sep, 2026
Vision and strategy
Aims to expand targeted radiopharmaceuticals to large patient populations using a novel miniprotein radioconjugate platform and a patient-centric, end-to-end manufacturing and supply chain.
Focuses on strong execution, with key milestones achieved in 2026 and momentum building for 2027, including Fast Track designation and IND clearance for lead programs.
Market opportunity
Targeted radiopharmaceuticals are projected to become a major category in cancer care, with a total addressable market potentially exceeding $60B post-2030.
Growth is expected to mirror the ADC market, driven by non-overlapping resistance, new technologies, and expansion into large tumor types.
Platform and supply chain
The miniprotein radioconjugate platform offers high tumor penetration, selective binding, fast clearance, and is isotope-agnostic for both imaging and therapy.
Manufacturing is resilient and scalable, with multiple suppliers for miniproteins and isotopes, and an operational GMP suite expected in 2H'26.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aktis Oncology
- Multi-tumor radiopharmaceuticals advance in phase I, backed by platform innovation and strong funding.AKTS
Morgan Stanley 24th Annual Global Healthcare Conference - Collaboration revenue doubled, R&D spending rose, and cash reserves support operations into 2029.AKTSQ2 2026
- Two first-in-class radiopharmaceuticals advance in phase I-B trials, with data expected in 2027.AKTSJefferies Global Healthcare Conference 2026
- AKY-2519 shows strong tumor targeting, low normal tissue exposure, and promising safety profile.AKTSStatus update
- Advancing miniprotein radioconjugates for cancer, with strong pipeline, partnerships, and cash runway.AKTSBank of America Global Healthcare Conference 2026
- Raised $365.4M in IPO, ended Q1 2026 with $538.5M cash, net loss $18.3M on higher R&D spend.AKTSQ1 2026
- AKY-2519 advances in Phase 1b trials for mCRPC and solid tumors, with key ASCO data ahead.AKTSStudy update
- FDA cleared INDs for AKY-2519; IPO raised $365.4M, funding operations into 2029.AKTSQ4 2025
- Innovative radiopharmaceutical platform advances with strong pipeline, partnerships, and cash runway.AKTSLeerink Global Healthcare Conference 2026
Next Aktis Oncology earnings date
Q3 202613 Nov, 2026
Aktis Oncology
Next Aktis Oncology earnings date
Q3 202613 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage